EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immune checkpoint therapy—current perspectives and future directions

Padmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, Bilal A Siddiqui, Pratishtha Singh, Ashwat Nagarajan, Jielin Liu, Sumit K Subudhi, Candice Poon, Kristal L Gant, Shelley M Herbrich, Swetha Anandhan und 4 weitere

Cell · 2023-04 · 186 (8) · 1652-1669

DOI: 10.1016/j.cell.2023.03.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell, 2023-04. Verfasst von Padmanee Sharma und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The Univ…. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms. Die Arbeit wurde bisher 1238-mal zitiert (Crossref) und nennt 188 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNeoplasmsHumansB7-H1 AntigenClinical Trials as TopicImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

CTLA-4ICTPD-1PD-L1combinatorial biomarkerscytotoxic T lymphocyte-associated protein 4immune checkpoint therapyimmune-related adverse eventsirAEsprogrammed cell death protein 1programmed death ligand 1reverse translation

Substanzen

B7-H1 AntigenImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The Immun…
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; MD Anderson UT Health Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer…
  • Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Zitieren

APA

Sharma, P., Goswami, S., Raychaudhuri, D., Siddiqui, B. A., Singh, P., Nagarajan, A., Liu, J., Subudhi, S. K., Poon, C., Gant, K. L., Herbrich, S. M., Anandhan, S., Islam, S., Amit, M., Anandappa, G., & Allison, J. P. (2023). Immune checkpoint therapy—current perspectives and future directions. Cell, 186(8), 1652-1669. https://doi.org/10.1016/j.cell.2023.03.006

Vancouver

Sharma P, Goswami S, Raychaudhuri D, Siddiqui BA, Singh P, Nagarajan A, et al. Immune checkpoint therapy—current perspectives and future directions. Cell. 2023;186(8):1652-1669. doi:10.1016/j.cell.2023.03.006

BibTeX
@article{Sharma2023,
  author = {Sharma, Padmanee and Goswami, Sangeeta and Raychaudhuri, Deblina and Siddiqui, Bilal A and Singh, Pratishtha and Nagarajan, Ashwat and Liu, Jielin and Subudhi, Sumit K and Poon, Candice and Gant, Kristal L and Herbrich, Shelley M and Anandhan, Swetha and Islam, Shajedul and Amit, Moran and Anandappa, Gayathri and Allison, James P},
  title = {Immune checkpoint therapy—current perspectives and future directions},
  journal = {Cell},
  year = {2023},
  volume = {186},
  number = {8},
  pages = {1652--1669},
  doi = {10.1016/j.cell.2023.03.006}
}
Kostenlos starten →